GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Tactile Systems Technology
Tactile Medical produces medical devices for the home treatment of lymphedema and venous insufficiency. Its stock price reflects the aging population and the increasing prevalence of these chronic conditions, as well as changes in Medicare rates.
Share prices of companies in the market segment - Therapeutic medical equipment
Tactile Systems Technology (TCMD) develops and markets home-use medical devices designed to treat chronic conditions such as lymphedema and venous insufficiency. We classify the company as "Therapeutic Medical Equipment." The chart below reflects trends in the home medical equipment sector.
Broad Market Index - GURU.Markets
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema and venous insufficiency. As a component of the GURU.Markets index, it represents the home healthcare sector. The chart below represents the entire market. See how Tactile shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
TCMD - Daily change in the company's share price Tactile Systems Technology
The daily price change of Tactile Systems, a medical device manufacturer, is a measure of its sensitivity to changes in the healthcare system. Change_co reflects volatility related to sales and tariffs. This metric is important for analyzing companies in the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Tactile Systems Technology, Inc. is a medical device company. This chart illustrates the high volatility of the MedTech industry. Comparing it to TCMD, which focuses on chronic disease treatments, helps assess the extent to which its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
Tactile is a manufacturer of medical devices for the treatment of lymphedema. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how Tactile shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Tactile Systems Technology
For Tactile Systems Technology, year-over-year performance is a story of home-based chronic care. The company's 12-month market capitalization growth reflects the growing number of patients using its pneumatic compression systems for lymphedema treatment, supported by broad coverage from insurance companies, including Medicare.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Tactile Systems Technology, Inc. is a medical device company developing devices for the treatment of chronic conditions such as lymphedema. The chart shows how its dominant position in this niche, the growing adoption of its technologies, and its reliance on reimbursement systems influence its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Tactile, with its lymphedema treatment systems, operates in the defensive sector. Demand for its medical equipment is driven not by economics but by patient needs. The company's stock price reflects stable, non-cyclical growth driven by ongoing demand for its unique technology.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Tactile Systems Technology
The value of Tactile, a medical device manufacturer, depends on the adoption of its technology. The monthly fluctuations on the chart reflect the growing number of patients using its lymphedema treatment systems and insurance company reimbursement decisions, which are key to its growth.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions, such as lymphedema. The company's growth depends on physician acceptance of its technologies and insurance coverage. The medical device sector chart reflects general trends that can be used to assess the commercialization of Tactile's products.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Tactile Systems Technology produces medical devices for the treatment of chronic diseases. Demand for its products is stable and largely independent of economic cycles. This gives the company's shares a defensive quality. Their performance often reflects sales success and insurance approvals rather than general market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Tactile Systems Technology
Tactile Systems produces medical devices for the treatment of chronic edema (lymphedema). Its weekly stock price reflects insurance company coverage decisions, clinical efficacy data, and the company's efforts to educate doctors and patients about its product.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
The medical device sector, where Tactile Systems operates, is benefiting from an aging population and advances in medicine. The graph below shows the overall dynamics of this market. It allows us to assess how successfully Tactile, focused on treating chronic edema, is developing its niche and staying ahead of the competition.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. Demand for its products is stable and unaffected by the economy. The chart helps assess how insulated the company's shares are from strong market fluctuations.
Market capitalization of the company, segment and market as a whole
TCMD - Market capitalization of the company Tactile Systems Technology
Tactile Systems Technology's market capitalization chart represents the market's valuation of its medical devices for treating chronic conditions. Its dynamics reflect investors' appreciation for its home-based lymphedema and venous insufficiency treatment systems. This growth reflects an aging population and the growing need for such medical solutions.
TCMD - Share of the company's market capitalization Tactile Systems Technology within the market segment - Therapeutic medical equipment
Tactile Systems Technology has developed and markets medical devices for the treatment of chronic conditions such as lymphedema. Its market capitalization in the therapeutic equipment segment reflects its leadership in this niche. The company's market share reflects how successfully its products are becoming standard treatments, improving the quality of life for millions of patients.
Market capitalization of the market segment - Therapeutic medical equipment
This chart shows the total market capitalization of the entire therapeutic medical equipment market. For Tactile Systems, which produces devices for treating lymphedema, this line is a quality-of-life map. The rising chart reflects the aging population and the growing need for medical devices for home-based chronic disease management.
Market capitalization of all companies included in a broad market index - GURU.Markets
Tactile Systems Technology produces medical devices for the treatment of chronic edema. Its market capitalization reflects the value of its technologies that improve patients' quality of life. Overall, this reflects the market share of businesses solving specific medical problems.
Book value capitalization of the company, segment and market as a whole
TCMD - Book value capitalization of the company Tactile Systems Technology
Tactile Systems Technology produces medical devices for the treatment of chronic diseases. Its book value is derived from its production capacity, product patents (such as the Flexitouch system), and inventory of finished devices. This is the material foundation for improving the quality of life for patients. How has it grown? The chart below shows.
TCMD - Share of the company's book capitalization Tactile Systems Technology within the market segment - Therapeutic medical equipment
Tactile Systems Technology produces medical devices for home use. Its business relies on its own manufacturing facility in Minnesota, where its systems for treating lymphedema and venous insufficiency are assembled. The chart shows the company's share of the physical infrastructure required to manufacture this type of medical equipment.
Market segment balance sheet capitalization - Therapeutic medical equipment
Tactile Systems, a medical device manufacturer, is a capital-intensive business. It requires manufacturing capacity to create its lymphedema treatment systems. The BCap_Seg chart for the medical device sector shows that success requires a robust manufacturing base.
Book value of all companies included in the broad market index - GURU.Markets
Tactile Systems' balance sheet represents its manufacturing capacity for creating medical devices for the treatment of lymphedema and venous insufficiency, such as compression systems. The company's assets include its technologies and manufacturing facilities. The chart provides an estimate of the material weight of this niche medical equipment manufacturer.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Tactile Systems Technology
Tactile Systems' balance sheet is its production capacity. The market premium is a valuation of its patented medical devices and its ability to effectively market them to patients and physicians. Its schedule is a premium for its commercial model.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Tactile Systems is a medical device company that produces devices for treating chronic edema. The chart shows how investors view its patented technology and its ability to expand its presence in the medical device market by demonstrating its effectiveness.
Market to book capitalization ratio for the market as a whole
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. The company's value lies in its patented technology and sales network. This creates a market valuation significantly above book value, reflecting the demand for its products.
Debts of the company, segment and market as a whole
TCMD - Company debts Tactile Systems Technology
Tactile Systems Technology, a manufacturer of medical devices for the treatment of chronic diseases, is using capital to expand its sales and marketing team, as well as R&D. This chart shows how the medtech company is funding the commercialization of its products, aiming to increase their market penetration and prove their clinical and economic value.
Market segment debts - Therapeutic medical equipment
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. The company incurs expenses not only on R&D and production but also on training physicians and patients. This chart shows how the company finances its commercial activities and how much it relies on debt capital to expand its market presence.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Tactile Systems Technology
Tactile Systems Technology produces medical devices for the treatment of chronic diseases. This is a stable and growing market. Debt can be used for R&D or expanding the sales team. This chart shows the company's financial policy. It helps assess how its debt load aligns with stable cash flows from medical equipment sales.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. This is a niche but important segment of the medical equipment market. The chart shows the overall debt burden in the sector, which helps assess how Tactile Medical finances the production and commercialization of its specialized products.
Debt to book value of all companies in the market
Tactile Systems Technology produces medical devices for the treatment of chronic diseases, which requires investment in R&D and regulatory approvals. This chart shows the market's overall leverage. It helps understand how the company manages its capital after entering the market: reinvesting profits in growth or using them to reduce its leverage.
P/E of the company, segment and market as a whole
P/E - Tactile Systems Technology
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema. This chart shows how the market is evaluating its products. The dynamics reflect growing physician acceptance of its therapy, demographic trends, and the shift of treatment from hospital to home.
P/E of the market segment - Therapeutic medical equipment
Tactile Systems is a manufacturer of medical devices for home treatment. This chart shows the average valuation for the medical device sector. It helps understand how investors view its business model, which benefits from the trend of moving treatments from hospitals to homes, and how it compares to its competitors.
P/E of the market as a whole
Tactile Systems Technology, Inc. develops and markets home-use medical devices for the treatment of chronic conditions such as lymphedema and chronic venous insufficiency. This chart reflects general trends in the healthcare sector. It helps understand whether TCMD is valued as an innovative medtech company solving important problems or whether its value moves in line with the overall market.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Tactile Systems Technology
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. The company's future profitability depends on expanding insurance coverage and physician adoption of its products. This chart reflects market expectations for increased demand for home therapy for chronic conditions.
Future (projected) P/E of the market segment - Therapeutic medical equipment
Tactile Systems Technology manufactures and sells medical devices for the home treatment of chronic conditions such as lymphedema and venous insufficiency. This chart reflects the company's future profitability expectations, indicating whether analysts believe demand for its products will grow and its ability to receive reimbursement from insurance companies.
Future (projected) P/E of the market as a whole
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. Their growth is driven by an aging population and increased awareness of the condition. This graph of overall market expectations highlights that demand for their products is not dependent on economic cycles.
Profit of the company, segment and market as a whole
Company profit Tactile Systems Technology
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. This chart shows how the company makes money from home care. Revenue growth depends on the number of patients using its systems and on insurance reimbursements from public and private payers.
Profit of companies in the market segment - Therapeutic medical equipment
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. Its products help patients manage their condition at home. The company's profitability depends on physician adoption of its technologies and insurance coverage. It is a player in the therapeutic medical equipment niche.
Overall market profit
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. Demand for its products is driven by medical needs. However, the overall economic situation, reflected in this chart, impacts healthcare systems, insurance coverage, and patient affordability, which may affect the rate of adoption of its therapies.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Tactile Systems Technology
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema. This chart reflects analysts' expectations for future profits. The forecast depends on expanding insurance coverage for their devices and the sales team's ability to convince doctors to prescribe their therapy.
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Tactile Systems Technology has developed and manufactures medical devices for the treatment of chronic swelling conditions such as lymphedema. Profitability forecasts for the medical equipment sector, shown in the graph, demonstrate the demand for home treatment solutions. This chart helps assess how Tactile Medical's products improve patients' quality of life and reduce healthcare costs.
Future (predicted) profit of the market as a whole
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. Demand for its products is driven by medical needs, but is also influenced by the availability of insurance coverage. The overall health of the economy, reflected in the chart, indirectly supports the stability of the healthcare system and its ability to pay for treatment.
P/S of the company, segment and market as a whole
P/S - Tactile Systems Technology
Tactile Systems Technology develops and manufactures medical devices for the treatment of chronic conditions such as lymphedema. This chart shows how investors value the revenue from sales of its unique products. A high valuation may reflect an unmet medical need and the patent protection of its technology.
P/S market segment - Therapeutic medical equipment
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema. This metric reflects the average revenue estimate in the medical device sector and helps understand the premium investors are willing to pay for products that improve patients' quality of life and reduce healthcare costs.
P/S of the market as a whole
Tactile Systems Technology has developed and manufactures medical devices for the home treatment of chronic conditions such as lymphedema and venous insufficiency. This chart provides an overview of how the market perceives the company's revenue, which offers innovative home therapy solutions, compared to average estimates.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Tactile Systems Technology
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. This chart shows how investors estimate its future revenue. This estimate is based on increasing patient adoption of its products and reimbursement from insurance companies.
Future (projected) P/S of the market segment - Therapeutic medical equipment
Tactile Systems Technology develops and markets medical devices for the home treatment of chronic conditions such as lymphedema. This chart compares the company's estimated future sales with other therapeutic equipment manufacturers. It reflects investor expectations for increased demand for its products as the population ages and diagnoses become more common.
Future (projected) P/S of the market as a whole
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. Demand for its products is driven by medical needs, not the economy. This chart shows the general background, but the drivers of Tactile Medical's growth lie in the healthcare industry, demographics, and insurance reimbursement.
Sales of the company, segment and market as a whole
Company sales Tactile Systems Technology
This chart shows the revenue of Tactile Systems Technology, a manufacturer of medical devices for the treatment of chronic conditions such as lymphedema. Revenue is generated from sales of its pneumatic compression systems, which patients use at home. Revenue growth reflects an aging population and the increasing prevalence of chronic conditions requiring ongoing care.
Sales of companies in the market segment - Therapeutic medical equipment
Tactile Systems Technology manufactures and markets home-use medical devices designed to treat chronic conditions such as lymphedema and venous insufficiency. This chart shows revenue in the therapeutic medical device sector. It reflects the growing trend toward home-based treatment of chronic conditions, which is more convenient for patients and cost-effective for the healthcare system.
Overall market sales
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. Demand for its products is driven by medical needs and insurance coverage. Economic cycles, as reflected in this chart, have minimal direct impact on its business, as treatment for such conditions cannot be delayed.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Tactile Systems Technology
Tactile Systems Technology develops and markets medical devices for the home treatment of chronic conditions such as lymphedema. This projected revenue chart reflects demand for its therapeutic systems. The growth is driven by expectations of an increase in the number of physicians prescribing its devices and expanded insurance coverage for these treatments.
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Tactile Systems Technology has developed and markets medical devices for the home treatment of chronic conditions such as lymphedema and venous insufficiency. Their systems help patients manage their conditions. This chart shows projected revenue for the therapeutic medical equipment sector, reflecting demand for home treatment devices.
Future (projected) sales of the market as a whole
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. Demand for its products is driven by medical needs and insurance coverage. Stable economic growth ensures a sustainable healthcare system, allowing more patients access to advanced treatments.
Marginality of the company, segment and market as a whole
Company marginality Tactile Systems Technology
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. The company's profitability depends on sales of its systems and insurance reimbursement. The chart shows how sales growth and efficient supply chain management enable the company to increase its profitability.
Market segment marginality - Therapeutic medical equipment
Tactile Systems Technology has developed and sells medical devices for the home treatment of chronic conditions such as lymphedema. This chart compares the company's profitability with other medical device manufacturers. The uniqueness of its products and the availability of insurance reimbursement allow it to maintain high margins and outpace competitors.
Market marginality as a whole
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. Demand for their products is driven by medical needs and insurance coverage, not the economic situation, as reflected in this graph. An aging population and increasing awareness of the disease are long-term drivers.
Employees in the company, segment and market as a whole
Number of employees in the company Tactile Systems Technology
Tactile Systems Technology produces medical devices for the treatment of chronic swelling conditions such as lymphedema. This chart shows the company's growing sales team. The increase in staff, primarily sales representatives, directly reflects efforts to raise awareness of the condition and integrate their products into clinical practice.
Share of the company's employees Tactile Systems Technology within the market segment - Therapeutic medical equipment
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema. Its direct sales and patient support model requires a significant staff of clinical specialists. This chart reflects its unique service model, showing the proportion of workers it employs in this medical device segment.
Number of employees in the market segment - Therapeutic medical equipment
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema. This chart shows growth in the home healthcare sector. The increase in sales representatives and clinical specialists reflects the company's efforts to educate doctors and patients about the benefits of its therapy, which can help avoid frequent hospital visits.
Number of employees in the market as a whole
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. Its growth, particularly in sales and marketing, reflects expanding market penetration. This total employment chart shows how the medical device sector is creating jobs and growing thanks to an aging population and the introduction of new treatments.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Tactile Systems Technology (TCMD)
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema and venous insufficiency. This chart demonstrates the high cost per employee. The market evaluates the company's patented technologies, its clinical data, and its ability to effectively collaborate with physicians and insurance companies.
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Tactile Systems Technology develops and markets medical devices for the treatment of chronic conditions such as lymphedema. In the medical device industry, this metric reflects the value of a product and the effectiveness of its commercial model. It demonstrates how successfully a company markets its devices, generating high value per employee.
Market capitalization per employee (in thousands of dollars) for the overall market
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. This metric reflects the company's medical device business. Value is generated through proprietary technology and direct patient sales. The market evaluates the effectiveness of this model and the clinical benefit of its products.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Tactile Systems Technology (TCMD)
Tactile Systems Technology produces medical devices for home use, primarily for the treatment of lymphedema and venous insufficiency. This is high-tech medicine. This chart shows how profitable their business model (selling devices to patients through doctors) is. Their high profit per employee is a result of the high margins of their patented devices.
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema. Their business model is sales-driven. This metric directly reflects the performance of their sales representatives, who must not only sell the device but also secure reimbursement from insurance companies.
Profit per employee (in thousands of dollars) for the market as a whole
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema. It's a MedTech business. Its profit per employee is a balance between R&D, production, and, most importantly, the direct sales team responsible for training doctors and patients on how to use these devices.
Sales to employees of the company, segment and market as a whole
Sales per company employee Tactile Systems Technology (TCMD)
Tactile Systems Technology produces medical devices for the treatment of chronic conditions such as lymphedema. This chart shows how the company is commercializing its products. The growth in revenue per employee reflects successful sales through its network of representatives and the adoption of its technology by doctors and patients.
Sales per employee in the market segment - Therapeutic medical equipment
Tactile Systems (TCMD) is a medical technology company that produces devices for the home treatment of chronic conditions such as lymphedema. This chart shows how much revenue each employee generates from sales of their devices. It's an indicator of the effectiveness of their direct-to-consumer (DME) model and the value of their products to patients.
Sales per employee for the market as a whole
Tactile Systems Technology (TCMD) produces medical devices for home use, primarily for the treatment of chronic conditions such as lymphedema (the Flexitouch system). It is a MedTech company. This metric reflects the productivity of their sales and production teams. Growth here means successful prescription of their devices by physicians.
Short shares by company, segment and market as a whole
Shares shorted by company Tactile Systems Technology (TCMD)
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema. This chart shows bearish bets. Bears may fear changes in the health insurance (reimbursement) system that will reduce profitability or the emergence of competing treatments.
Shares shorted by market segment - Therapeutic medical equipment
Tactile Systems (Tactile Medical) produces medical devices for the home treatment of lymphedema and venous insufficiency (compression systems). This indicator measures pessimism. "Short" here is a bet that insurance companies will refuse to reimburse for their expensive devices.
Shares shorted by the overall market
Tactile Systems Technology produces medical devices for the home treatment of chronic conditions such as lymphedema. This chart illustrates the overall market fear. The medical equipment sector is considered a defensive one, as people don't skimp on their health. However, in a panic, investors may fear that healthcare systems will cut back on purchasing even essential equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Tactile Systems Technology (TCMD)
Tactile Systems (TCMD) is a medical device company. Their main product is pneumatic compression devices (Flexitouch) for the home treatment of lymphedema and venous ulcers. This chart measures momentum. It shows "overbought" (above 70) amid strong sales growth or "oversold" (below 30) amid insurance reimbursement issues.
RSI 14 Market Segment - Therapeutic medical equipment
Tactile Medical (TCMD) is a medtech company. They produce medical pumps (pneumatic compression) for the home treatment of lymphedema (swelling). The RSI_14_Seg for their segment (medtech) shows whether the sector is overbought. This helps us understand whether TCMD's growth is a niche product or a sign of general overheating in the medical device sector.
RSI 14 for the overall market
Tactile Systems (TCMD) produces medical devices (compression) for home use. This chart shows that its business is "defensive." Demand for its products (treatment of chronic diseases) is not affected by euphoria or panic. In times of panic, investors appreciate this stable, non-cyclical cash flow.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TCMD (Tactile Systems Technology)
Tactile Systems (TCMD) produces medical devices for the home treatment of chronic swelling, such as lymphedema. This chart shows the average target price. It reflects analysts' views on the growth of the home therapy market and the company's ability to receive reimbursement from insurance companies (Medicare).
The difference between the consensus estimate and the actual stock price TCMD (Tactile Systems Technology)
Tactile Systems (TCMD) is a medical device company that treats chronic swelling (lymphedema) at home. Their flagship product (Flexitouch) is an advanced pneumatic compression system (an inflatable vest/sleeve). This chart shows analysts' confidence in their ability to secure insurance reimbursement and expand the market for this at-home therapy.
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Tactile Systems Technology (TCMD) is a medical company that produces wearable pneumatic compression devices for the treatment of lymphedema (edema) at home. This chart shows general expectations for the therapeutic medical equipment sector. It reflects whether experts believe the home treatment market will grow.
Analysts' consensus forecast for the overall market share price
Tactile Systems (TCMD) is a medical company that helps people with chronic swelling. Their key product is the Flexitouch compression system, which patients use at home to treat lymphedema. This chart shows the general sentiment of experts. It reflects analysts' confidence in the stability of the healthcare system and Medicare reimbursement.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Tactile Systems Technology
Tactile Medical is a medical technology company for chronically ill patients. Their business is pneumatic compression. They manufacture and lease (through insurance) inflatable vests and sleeves that treat lymphedema and venous ulcers at home. This chart is a barometer of their reimbursement. It likely reflects their ability to secure Medicare/insurer approval for their high-margin devices.
AKIMA Market Segment Index - Therapeutic medical equipment
Tactile Medical (TCMD) is a medtech leader in chronic edema treatment; the company produces unique pneumatic compression devices (Flexitouch) that patients use at home to treat lymphedema. This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does this niche (DME) model (TCMD) differentiate itself from its average medtech competitor?
The AKIM Index for the overall market
Tactile Medical is a leader in the development of home therapeutic devices for the treatment of lymphedema and chronic venous insufficiency. This chart, reflecting the market average, provides context. It helps assess how this MedTech growth story, driven by insurance reimbursement and diagnoses, compares to overall macroeconomic trends.